Magnusiomyces capitatus (de Hoog et al.) de Hoog et Smith
商品貨號
B182125
Deposited As
Blastoschizomyces capitatus (Diddens et Lodder) Salkin et al.
Strain Designations
7
Application
Biomedical Research and Development Material
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Preceptrol®
no
Comments
reference strain for restriction endonuclease analysis
fluconazole-resistant
Medium
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
ATCC® Medium 200: YM agar or YM broth
ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
Growth Conditions
Temperature: 30°C
Atmosphere: Typical aerobic
Name of Depositor
D Dantonio
Special Collection
NCRR Contract
Isolation
Blood of 38-year-old man with myeloma, Italy
References
D'Antonio D, et al. Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients. J. Clin. Microbiol. 34: 753-755, 1996. PubMed: 8904454
D'Antonio D, et al. Onychomycosis caused by Blastoschizomyces capitatus. J. Clin. Microbiol. 37: 2927-2930, 1999. PubMed: 10449477
